Hello, I am about to begin the 12 weeks of treatment using the Sofo/Dac sourced through Mesochem. Though I have found a doctor in Tokyo, Japan willing to take blood tests he is not very supportive and insists that I pay all costs - actually 200/300% of actual costs as I am not covered for treatment by health insurance as I do not have a prescription. Nonetheless, I am grateful that he is willing to do the tests so accept the situation. He has been pushing the Interferon treatment as it is covered by health insurance but I rejected that option. He is also very, very hesitant to discuss anything related to treatment so I am in need of some advice.
First, some basic background info.
I have had my initial blood work done and have had a CT scan showing no cirrhosis/fibrosis/fatty liver. He will not refer me to a hospital for a Fibroscan and I cannot access it without a referral. I did not have the meds tested for purity, etc., as it is not possible to do so in Japan but I believe them to be safe as many people on the forum are using meds from the same company.
As of two weeks ago some of my numbers were: AST = 45, ALT = 66., HCV = 5.6 L.IU/mL. All of my other blood work shows that I am very healthy for a 53 year old.
On to the questions:
The doctor has recommended that I have blood tests done every 2 weeks during treatment. This seems excessive as the norm seems to be after 4 and 12 weeks, then perhaps after an additional 12 or 24 weeks to confirm there has been no relapse.
1. Can anyone confirm how often I should have blood tests? Is there any value in having tests every two weeks other than perhaps after the initial 2 weeks to confirm no negative reaction to the meds?
2. What tests should be done other than the following: Complete blood count (CBC), creatinine level, calculated glomerular filtration rate (GFR), and hepatic function panel are recommended after 4 weeks. Do the same tests need to be done at 12 weeks or just a HCV viral load test?
3. What are alarm bells to consider with the test results in regards to stopping treatment other than if quantitative HCV viral load has increased by greater than 10-fold (>1 log10 IU/mL) on repeat testing at week 6 (or thereafter), then discontinuation of HCV treatment is recommended?
If anyone has detailed feedback regarding the above questions I would be very grateful for any assistance.
Thanks very much. Regards, Gary